Assay-kits

SensoLyte® 490 HCV Protease Assay Kit Fluorimetric 500 assays - 1 kit

582,00
Check your price
  • Cat.Number : AS-71126
  • Availability :
    In stock
  • Shipping conditions : Ice delivery fees must be applied

Select specification

Quantity

HCV protease is identified as an important drug-screening target. The SensoLyte® 490 HCV Protease Assay Kit uses an optimized FRET peptide substrate for the continuous measurement of HCV NS3/4a activity. This FRET substrate is cleaved specifically by HCV NS3/4a protease thereby liberating the C-terminal peptide-fluorophore fragment from the proximity quenching effect of the dark quencher, resulting in a more than 10-fold increase in fluorescence. This assay can detect HCV NS3/4a protease activity at 1 pmole.

Specifications

Packaging
Kits components
  • Component A: HCV NS3/4A protease substrate Ex/Em=340 nm/490 nm upon cleavage: 600 µL Component B: EDANS, fluorescence reference standard: 100 µM DMSO solution, 20 µL Component C: 2X Assay buffer: 50 mL Component D: Stop solution: 30 mL Component E: DTT: 1 M, 1 mL X 2 vials Component :F Pep4AK, HCV NS3 protease cofactor: 300 µL, 600 µM
Properties
Absorbance (nm)
  • 340
Emission (nm)
  • 490
Storage & stability
Storage Conditions
  • Store all kit components at -20°C. Protect Components A and B from light. Components C and D can be stored at room temperature for convenience.
Activity
Application
Biomarker Target
Detection Method
Detection Limit
  • 1 pmole
Research Area
Sub-category Research Area
Usage
  • Research use

You may also be interested in the following product(s)

Tube of HCV NS3 Protease Inhibitor2 peptide

HCV NS3 Protease Inhibitor 2 - 1 mg

Cat.Number : AS-25346
390,00
Tube of HCV NS3/4A Protease Substrate peptide

HCV NS3/4A Protease Substrate - 1 mg

Cat.Number : AS-60798
670,00
Tube of HCV Protease FRET Substrate peptide

HCV Protease FRET Substrate (RET S1)

Cat.Number : AS-22991
565,00

Citations

2-Arylmethylaminomethyl-5,6-dihydroxychromone derivatives with selective anti-HCV activity.

Bioorg Med Chem Lett . 2011 Jun 01 ; 21(11) 3202 | DOI : 10.1016/j.bmcl.2011.04.055

  • H.R. Park
  • et al

Ceestatin, a novel small molecule inhibitor of hepatitis C virus replication, inhibits 3-hydroxy-3-methylglutaryl-coenzyme A synthase.

J Infect Dis. . 2011 Aug 15 ; 204(4) 609 | DOI : 10.1093/infdis/jir303

  • L.F. Peng
  • et al

Mutations in HCV non-structural genes do not contribute to resistance to nitazoxanide in replicon-containing cells.

Antiviral Res . 2011 Sep 01 ; 91(3) 233 | DOI : 10.1016/j.antiviral.2011.05.017

  • C. Yon
  • et al

A method to simultaneously monitor hepatitis C virus NS3 helicase and protease activities.

Methods Mol Biol . 2010 Jan 01 ; 587 223 | DOI : 10.1007/978-1-60327-355-8_16

  • D.N. Frick
  • et al